a natural complex of lipopolysaccharide occurring in the outer layer of the bilayered gram-negative bacterial cell. From the circulating blood cells of Limulus polyphemus, called amebocytes, a clear lysate is obtained that forms an opaque gel in the presence of extremely small concentrations of bacterial endotoxins (1).
Some techniques to determine endotoxins are known, such as the chromogenic (color development) and the turbidimetric (turbidity development) tests, both of which can provide valuable quantitative and qualitative information about the endotoxin concentration in samples (2) .
The quantitative kinetic chromogenic method measures the chromophore released from a suitable chromogenic peptide by the reaction of endotoxins with the Limulus amebocyte lysate (LAL) reagent. The chromogenic method is based on bacterial endotoxin activation of the coagulating enzyme, which reacts with a colorless synthetic substrate. This substrate consists of a small peptide linked by the C-terminal arginine to the p-nitroaniline chromophore molecule. Once the cascading enzymatic reaction is activated, the coagulating enzyme causes the release of the yellow p-nitroaniline molecule. The color development is proportional to the endotoxin concentration in samples. The chromophore release can be spectrophotometrically monitored at 405 nm (optical density), and either the time to reach a predetermined absorbance of the reaction mixture or the rate of color development is measured (/-3).
A rapid quantitative kinetic chromogenic test in an automated portable test system has been developed for inprocess and end-product determination of bacterial endotoxins in water using the LAL.
Preparatory tests should be conducted to verify that the criteria for the standard curve are valid, to confirm that the sample solution does not inhibit or enhance the reaction, and thus to ensure that the chromogenic technique is precise and valid for some specific sample (2, 4) . The aim of this work was to validate a rapid technique using the quantitative kinetic chromogenic method for determination of bacterial endotoxin in 18F-FDG, 99mTc, and the Iyophilized reagents methylene diphosphonic acid (MDP) and RAPID 
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pyrophosphate for labeling with 99mTc radiopharmaceuticaIs with no interfering factors.
MATERIALS AND METHODS
Experiments were performed on 3 consecutive batches of 18F-FDG, 99mTc, MDP, and pyrophosphate produced at the Nuclear Energy and Research Institute of São Paulo, Brazil, using a portable test system from Endosafe, Inc. Single polystyrene Endosafe cartridges (Figs. IA and lB) containing dry LAL reagents, control standard endotoxin, and synthetic color substrate were used.
The maximum valid dilution (MVD) is the maximum allowable dilution of a specimen at which the endotoxin limit can be determined. This dilution is applied to injections or to solutions for parenteral administration in the form constituted or diluted for administration. The general equation (5, 6) to determine maximum valid dilution is as follows:
endotoxin limit concentration x potency of product MVD 
= ----------------À
The maximum valid dilution obtained was 25 X 1.00, which, divided by 0.05, equals 500.
Serial dilutions of 1: 1, 1:5, 1:10, 1:20, and 1:50 for 18F_ FDG, 99mTc, MDP, and pyrophosphate, and also 1: 100 and 1:200 for MDP and pyrophosphate, were prepared by dilution with sterile and pyrogen-free water. Samples (25 J-LL) were pipetted into the cartridge wells, and the temperature of the reaction was maintained at (37 :±: l)°C. The optical density was continuously monitored at 405 nm, and the overall time of the test was 15-20 mino
To be considered free of interfering factors under the conditions of the test, the measured concentration of the endotoxin added to the sample solution must be within 50%-200% of the known added endotoxin concentration after subtraction of any endotoxin detected in the solution without added endotoxin. The midpoint of the standard curve is the known added endotoxin concentration (0.5 EU mL -I) (2) .
The test is not valid unless the following criteria are met: the product standard curve must meet the test for linearity, that is, correlation coefficient is equal to or greater than the where the endotoxin limit concentration is specified in the individual monograph in terms of endotoxin units (EU) per milliliter (6) . For radiopharmaceuticals, the endotoxin limit is 175 EU per dose. The maximum administered dose in volume of the studied products is 7 mL; thus, dividing 175 by 7 gives a result of 25 EU mL -I. The potency of the product for drugs administered on a volume-per-kilogram basis is 1.0 mL mL -I (5).
There are 3 defined concentrations in the archived kinetic chromogenic standard curve: 5.0, 0.5, and 0.05 EU mL-I (2 logs). 11 . is the lowest point in the endotoxin standard curve-that is, the lowest endotoxin concentration that can be detected in the sample (2) . :.,
, , In the chromogenic method, product dilution is higher than in the gel c\ot method (maximum valid dilution = 200 for radiopharmaceuticals with 0.125 EU mL -I LAL reagent sensitivity), and the validation experiments were performed to determine the minimum interfering dilution.
Because of the linear quantitative correlation between log of the endotoxin concentration and log of the reaction time, praduct endotoxin concentration and praduct positive control can be determined when the assay parameters meet (9) the acceptability criteria presented in Table I .
An out-of-specification percentage recovery of product positive control is associated with a caIculated product endotoxin concentration that expresses any interference (inhibition ar enhancement) (9) .When any criteria, mainly absolute value of 0.980; the endotoxin recovery is within 50%-200%; the coefficient of variation is less than 25% on both sample and positive contrai channels; and the endotoxin concentration in the test product after correction for dilution and concentration is less than the endotoxin limit for the radiopharmaceutical (2) .
Each test cartridge has 4 channels, 2 for the posítlve control, which contains a known endotoxin concentration, and 2 for the negative or sample contraI.
The following parameters were caIculated by interpolation on an archived standard curve in the range of 5.0-0.05 EU mL -I, using the software in the sample reader: product endotoxin concentration (the amount of endotoxin in the product per volume after correction for dilution, expressed as EU mL -I), praduct positive contrai (the sample contaminated with a known endotoxin concentration [0.5 EU mL -I], expressed as EU mL -I), percentage sample coefficient of variation (the variation between the test sampies in the 2 negative control channels), percentage endotoxin spike coefficient of variation (the variation between the test samples in the 2 positive contrai channels), and percentage recovery of product positive control (the measured concentration of the endotoxin added to the sample solution after subtraction of any endotoxin detected in the solution without added endotoxin).
RESULTS
The percentage recovery of praduct positive control for serial dilutions of 3 batches of 18F-FDG and 99mTc, and of MDP and pyraphosphate, is shown in Figures 2A and 2B and Figures 3A and 3B , respectively.
Undiluted samples of each product interfered with the test. Experiments showed better results above a 1:5 dilution factor for 18F-FDG and 99mTc, I :20 for MDP, and I: 100 for pyrophosphate.
Pyrophosphate showed significant interference below a 50x dilution; therefore, greater dilutions were performed.
DISCUSSION
To avoid interfering test conditions, the United States Pharmacopeia (6) allows drug product dilutions based on the established endotoxin limits, such as 175 EU per dose of radiopharmaceuticals. These limits may be used to determine the extent of dilution (maximum valid dilution) that may be applied to overcome an interference problem without exceeding the limit for endotoxin concentration (5) (6) (7) (8) . Because the sample volumes were small (25 fLL), it was important to have skilled analysts to manage the micropipettes in order to minimize errors.
We observed that there was a specific dilution limit without interference for each radiopharmaceutical and that above that limit, the required parameters 
CONCLUSION
The portable test system is a rapid, simple, and accurate technique using the quantitative kinetic chromogenic method for bacterial endotoxin determination. For this reason, the system is practical for radiopharmaceutical uses and tends to be the method of choice for the pyrogen test.
For 18F-FDG, 99mTc, MDP, and pyrophosphate, the validation was successfully performed.
Cell therapy for neurologic disorders will benefit significantly from progress in methods of noninvasively imaging cell transplants. The success of current cell therapy has varied, in part because of differences in cell sources, differences in transplantation procedures, and lack of understanding of cell fate after transplantation. Standardization of transplantation procedures will progress with noninvasive imaging. In turn, in vivo imaging will enhance our understanding of neural transplant biology and improve therapeutic outcomes. The goal of this study was to determine the effect of a 99mTc-based probe on neural stem and progenitor cell transplants and validate the SPECT images of the transplanted cells. Methods: We previously developed a method to label neural stem and progenitor cells with 99mTcto visualize these cells in the brain with SPECT.
The cells were initially labeled with a permeation peptide carrying a chelate for 99mTc. The proliferation and differentiation characteristics of the labeled cells were studied in tissue culture. In parallel experiments, the labeled cells were stereotactically injected into the rat brain, and the site of transplantation was verified with histochemistry and phosphorimaging. Results: The accuracy of the transplant location obtained by SPECT was confirmed by comparison with phosphorimages and histologic sections of the brain. The labeling did, however, decrease the proliferative capacity of the neural stem and progenitor cells. Conclusion: The labeling technique described here can be used to standardize the location of cell transplants in the brain and quantify the number of transplanted cells. However, a 99mTc-based probe can decrease the cellular proliferation of neural progenitor cells. NSPCs are capable of self-renewal and differentiation into the 3 main celllineages of the central nervous system: astrocytes, oligodendrocytes, and neurons (6) . NSPCs can be isolated from fetal, embryonic, and adult brain sources and can be expanded in vitro as heterogeneous aggregates of cells termed neurospheres. The properties of NSPCs make them an attractive therapeutic option for neurologic disorders. Stem cell therapy in animal models of PD has produced variable outcomes. One study demonstrated that embryonic stem cells could be used to successfully treat PD; however, 40% of these animais had teratoma formation (7). Studies with adult progenitor cells have shown that although there is graft survival, functional recovery is not consistent (8) . ln contrast, other reports have successfully demonstrated graft survival with the expression of tyrosine hydroxylase, the rate-limiting enzyme in dopamine production, and corresponding functional improvements (9) . However, in clinical trials of PD, there has been limited success with transplantation therapy (10, 11) . At this time, cell transplantation therapy is highly variable, in part because of difficulties in achieving reproducible cell grafts.
It is important to understand conditions that affect transplant survival and cell fate to decrease the variability observed in transplantation experiments. Molecular imaging techniques can provi de valuable information about transplant variables that will enhance transplantation outcomes. There is a need to standardize transplantation procedures using short-term assessment methods and to understand the fate of the transplanted cells using long-term tracking studies.
A previous study found that despite the use of ultrasound-guided injection and highly trained personnel, cell placement was performed correctly only approximately 50% of the time (12) . The number of transplanted cells has been shown to affect therapeutic outcome (13, 14) . The number of cells transplanted can, in theory, be determined with good accuracy using nuclear imaging methods, including SPECT and the appropriate molecular imaging probe. The ability to determine the number of cells injected into Tat-based peptides are useful tools for incorporating radiolabels, fluorescent protein, or MRI contrast agents into cells (15) (16) (17) (18) (19) . When coupled to 99mTc, cells can be labeled with a relatively inexpensive and widely available radionuclide, the short-term shutdown of the Chalk River reactor notwithstanding. 99mTc has a half-life of approximately 6 h and decays with an emission of 140-keV -y-rays. These are optimal physical characteristics for -y-camera imaging, and this isotope imparts a low dose-burden to patients (20) . We have previously shown that we can label a chelate-derived version of a permeation peptide and use it to monitor preliminary transplants (21) . An initial study of 99mTc-labeled celIs found no significant effects of the probe on DNA damage or the viability of NSPCs. The aim of this study was to validate the correlation of imaging results with histochemistry and to assess the effect of the probe' on celI proliferation and differentiation to determine whether this label is suitable for imaging celI transplants.
MATERIALS AND METHODS

Maintenance of Animal Colonies
All animal experiments were performed in accordance with the guidelines specified by the Canadian Council on Animal Care and were appraved by the Animal Research Ethics Board of McMaster University.
High-Performance Liquid Chromatography (HPLC)
Analytic HPLC was performed using a Pursuit Cl8 5-l-Lm, 2.4-mm MetaGuard column (Varian) and a C18 column (4. Semipreparative HPLC was performed using a C-18 3-l-Lm Luna semipreparative column (150 x 10 mm; Phenomenex). Solvent A was H20 containing 0.05% TFA, solvent B was acetonitrile containing 0.05% TFA, and the gradient was run using the same protocol as for analytic HPLC. The flow rate was 4.0 mL min -I, and the runs were monitored at À. = 254 nm.
Solid-Phase Peptide Synthesis
Solid-phase peptide synthesis was performed as previously described (21) . Briefly, peptides were made on a Fmoc-glycine-loaded Wang resin and, after completion, were cleaved from the resin using a TFA mixture containing 2% 1,2-ethanedithiol, 2% water, and 2% triisoprapylsilane. Peptides were lyophilized to yield the peptide and the corresponding rhenium standard.
Preparation of 99mTc Probe
Preparation of the probe was based on a previously described pracedure (21) . For peptide labeling, 4.0 mg (2.1 x 10-6 moI) of the peptide in 200 I-LLof distilled deionized water were added to the 99mTc solution. The reaction was heated in a microwave at 120°C for 5 mino
The solvent was removed using a V 1O evaporation system (Biotage Inc.), and the cru de product was redissolved in 0.5 mL of distilled H20 using the VlO system. The crude reaction was purified using semipreparative HPLC, and radiochemical purity (98%) was determined using analytic -y-HPLC.
Preparation of Neurospheres
Neurospheres were prepared as previously described (21) . Briefly, NSPCs were harvested from 1-to 3-d-old pups. The cells were cultured as neurospheres and used for subsequent experiments between the first and fifth passages.
Labeling of Dissociated Neurospheres with 99mTc Probe
Neurospheres were dissociated using TrypLE Express (Invitrogen). The resulting cell pellet was resuspended in serum-free medium. The cell counts were determined using trypan b1ue exc1usion dye. Cells were p1ated in tissue culture dishes at a concentration of 10,000 cells/mL. The cells were incubated with 27.3 pmo1 (592 MBq) of 99mTc in 0.01 M phosphate-buffered saline at 37°C for 20 min in a 95% 02> 5% CO2, incubator. The labeled cells were washed and resuspended in the apprapriate amount of medi um for the subsequent experiments. Labeling efficiency was determined using a dose calibrator that had been calibrated using a National Institute of Standards and Technology-traceable standard and reference standards over a range of activities. Contrai cells were prepared in an identical manner using 0.0 I M phosphate-buffered saline in place of the 99mTc probe. For some experiments, a portion of the labeled cells was coincubated with cell-tracker orange (Molecular Probes) according to the manufacturer's instructions to label the cells for identification by fluorescence microscopy.
Proliferation of Labeled NSPCs
Cells were labeled with 99mTc, 27.3 pmol of rhenium standard, or peptide as described previously (22) . Control cells were labeled with an equal volume of 0.0 I M phosphate-buffered saline for 20 mino Proliferation was monitored using a BrdU Cell Praliferation Assay (Chemicon Intemational) according to the manufacturer's instructions.
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Differentiation of labeled NSPCs
After labeling with the 99mTc prabe, 27.3 pmol of rhenium, or peptide, the celIs were plated onto coverslips coated with POlY-L-lysine (Sigma) and laminin (lnvitragen) in aI: I ratio of serum-free medium to serum-free medium without epidermal grawth factor (Sigma), fibroblast growth factor 2 (Sigma), and heparin (Sigma) containing 1.0% fetal bovine serum (Biowest). The celIs were differentiated for 10 d at 37°C in 95% 0z and 5% COzo The celIs were then fixed in acetone, and celI differentiation was assessed using immunocytochemistry. The neuronal and glial phenotypes were identified using monoclonal anti-I3III-tubulin (1:1,000; Pramega) and polyclonal anti-glial fibrillary acidic protein (l: 100; Dako), respectively. Secondary antibodies included donkey anti-mouse AlexaFluor 594 (1: 1,500; lnvitragen) and goat anti-rabbit fluorescein isothiocyanate
(1: 100; Cedarlane).
NSPC Transplantation
Three-month-old Sprague Dawley rats were anesthetized by the gaseous anesthetic isoflurane (2.5%-3.0%). Buprenorphine in sterile saline was injected subcutaneously as an analgesic. Rats were placed in a stereotactic apparatus (David Kopf lnstruments) in preparation for surgery. A second analgesic, lidocaine, was applied topicalIy on the surface of the scalp before the incision. An incision was made along the top of the skull, and the overlying muscle was scraped away fram the skulI surface. At the coordinates given below (from Bregma and the dura mater), a dremel drilI was used to make a smalI hole thraugh the skulI. The celIs were transplanted with a 1O-/-LLHamilton syringe lowered into the striatum of the rats (fram Bregma and the dura anteraposteriorly, mediolateralIy, and dorsoventralIy, 3 /-LLwere injected at -1.0, -3.0, and -4.0 mm, respectively [nose bar = O mm]). The syringe was left in place for 10 min and then slowly removed. The incision was closed with 4-0 silk sutures, and the rat was alIowed to recover fram the anesthetic.
SPECT of Cell Transplants
The rats were anesthetized using isoflurane (2.5%-3.0%). SPECT images were acquired using an X-SPECT system (Gamma Medica-ldeas) and a high-resolution paralIel-hole collimator folIowed by a CT scan. The dual-head SPECT/CT system has a SPECT field of view of 10 x 10 cm with a spatial resolution of 2-3 mm. The -y-cameras were fitted with low-energy, high-resolution paralIel-hole collimators. One ratation was acquired over 64 prajections at 100 s/prajection.
SPECT images were reconstructed using iterative orderedsubsets expectation maximization with detector response compensation. ln total, 2 iterations with 8 subsets were used, and the reconstructed images were processed with a 3-dimensional gaussian filter of 2 mm in fulI width at half maximum. Analysis was done by drawing a 3-dimensional region of interest araund the celI transplant using AMlDE software (version 0.9.1; http://amide.sourceforge.net).
The mean counts were obtained and compared with a calibration curve. The CT component of the X-SPECT system, which has a flat-panel-detector field of view of 10 x 10 em, was used for anatomic coregistration. CT information was aequired using 75-kVp x-rays and a tube eurrent of 265 /-LAwith a spot size of 50 /-Lm. Over 360°, 512 projections were acquired, and they were processed with a modified Feldkamp cone-beam reconstruetion (version 6.0; Cobra-Exxim). The resulting image had a matrix of 512 x 512 x 512 and a reconstructed voxel size of 155 /-Lm.
Phosphorimaging of Dissected Rat Brains
lmmediately after imaging, the rat was sacrificed and the brain was removed, flash-frazen, and cut into 20-/-Lm sections with a cryostat. The sections were exposed to phosphorimaging film for 15 min and developed using a Storm 840 phosphorimager and lmageQuant TL (GE Healtheare).
Statistics
The data are presented as mean ::'::: SEM. Statistical analysis was performed using l-way or 2-way ANOVA with a post hoc Tukey test or a t test using Prism software (version 5; GraphPad). Signifieance is expressed with a confidence interval of P < 0.05.
RESUlTS
Proliferation of labeled NSPCs
The praliferation of NSPCs after labeling was assessed using the BrdU celI proliferation assay. Labeled celIs were incubated with the BrdU reagent for 24 h at 37°C and analyzed in paralIel with the contraI celIs. This assay assesses the amount of BrdU incorporated into newly synthesized DNA and is directly proportional to the number of cells that have divided within the 24-h period. 99mTc_,rhenium-, or peptide-labeled NSPC praliferation was normalized to control celIs that had been incubated with an equal volume of 0.01 M phosphate-buffered saline. This accounts for differences in the primary celIs and the age of the celIs, because the age of the celIs can affect their praliferative ability (22) . The praliferative abilities of rhenium-and peptide-labeled celIs did not significantly differ from one another (103.4% ::'::: 7.8% and 108.5% ::'::: 21.2%, respectively) (Fig. 1) . 99mTe-labeled eelIs showed a significant decrease in praliferation (25.4% ::'::: 13.1 %) compared with rhenium-and peptide-labeled celIs (Fig. 1) , indicating that the difference in praliferation was most likely eaused by 99mTc rather than the peptide itself.
Differentiation of labeled NSPCs
NSPCs isolated fram wild-type mouse pups were labeled with 99mTc, rhenium, and peptide. Labeled eelIs were differentiated for 10 d in medium containing 1.0% fetal bovine serum and depleted of grawth factors. The percentages of neuronal and glial eelIs were expressed as a pereentage of the total celI number determined by 4' 6' -diamidino-2-phenylindole staining of the nuclei. 99mTc_, rhenium-, ànd peptide-labeled celIs were normalized to control celIs 99mTc is the most widely used radionuc1ide in diagnostic medicine. It has a reasonably long half-life (6 h) and is readily available in most hospitaIs, making 99mTc-based cell labeling agents accessible to the research community at a reasonable cost. This consideration is important in view DISCUSSION When cell differentiation was compared between the 99mTc, rhenium, and peptide graups, a trend toward increased neuranal differentiation was found in both the 99mTc and rhenium graups, with the former showing the greatest neuronal differentiation.
However, because of the variability in cell differentiation, this trend did not reach significance ( Fig. 2A) .
SPECT of Cell Transplants
To determine whether the SPECT images accurately illustrate the location of transplanted NSPCs, in vivo and ex vivo imaging studies were performed using complementary cell labels. Rats were transplanted with 99mTc-Iabeled NSPCs or NSPCs double-Iabeled with cell-tracker arange (a lipophilic dye) and 99mTc. Immediately after surgery, a SPECT/CT image was acquired, the rats were euthanized, and the brains were flash frazen for histology ar phosphorimaging to confirm that the SPECT images corresponded to the transplanted cells (Fig. 3) . The SPECT image and the phosphorimage demonstrate the specificity of the activity to the area of the transplanted cells (Figs. 3A-3D ). As further confirmation, NSPCs double-Iabeled with cell-tracker arange and 99mTc were transplanted into the forebrain. The SPECT findings correlated with the location of the cells on histology (Figs. 3E-3J ). of the number of transplantations undertaken in a typical preclinical study. An additional benefit of 99mTc is that it imparts a low dose-burden that should limit potential radiation damage to labeled cells.
ln a previous study, we developed a method to label cells for imaging after their injection into the brain (21) . The procedure involved the use of a new chelate system, single-amino-acid chelate quinoline, which can be labeled with 99mTc for in vivo imaging studies or with rhenium for ftuorescence imaging studies. The chelate and the rhenium complex can be conveniently incorporated into peptides as if they were natural amino acids. For cell tagging, a permeation peptide, HIV Tat48_57, was derivatized with single-amino-acid chelate quinoline or the rhenium complex, and the probes were used to label cells. Preliminary assays showed that labeling was achieved without decreasing cell viability or inducing DNA damage.
In the current study, we found a decrease in the proliferative capacity of cells labeled with 99mTc, in comparison to rhenium-and peptide-labeled cells. This decrease may be due to radiation-induced DNA damage, which can cause cell death or arrest the cell cycle occurring outside the previously examined 24-h time point. Radiationinduced apoptosis occurs in murine lymphocytes after exposure to 137CS. The apoptotic index peaks at 8 h, and apoptosis declines rapidly after 16 h (23). Because DNA damage was examined previously at 24 h, 99mTc-induced DNA damage may have been repaired by this time or cells with irreversible damage may have been eliminated by apoptosis, as would account for the decrease in proliferation.
DNA damage caused by Auger electron emission from 99mTc has been reported in the literature (24) (25) (26) . Haeftiger et aI. (24) reported that DNA damage caused by the nuclear localization of 99mTc did not reduce viability at 24 h but inhibited proliferation. At 5 d there was nuclear damage, and cell death occurred 9 d after labeling as a result of radiation-induced mitosis-linked death or radiation-induced cell senescence (24) . The authors noted that incubation with less activity produced initial cell damage but was followed by recovery and exponential growth. For their study, cells were incubated for 36 h and the lowest concentration of peptide was in the nanomolar range, whereas our method incubated the cells for 20 min with peptide concentrations in the picomolar range. Based on the decrease in the concentration of the radiolabeled peptide and the shortened incubation in our study, it is possible that cells experienced cell-cycle arrest, slowing the proliferative capabilities of the labeled cells in comparison to the nonradioactive peptide. DNA damage assays and apoptotic assays should be investigated further to verify DNA integrity and the viability of the 99mTc-Iabeled NSPCs at later time points.
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The decrease in proliferation with the present reagents may prove useful for certain cell types. For example, embryonic stem cells continue to proliferate after transplantation, potentially resuIting in teratoma formation (7) . A reduction in the proliferative capacity of these cells may result in more effective treatment with lower side effects.
For cases in which a mixed population of glial cells and neurons contains an abundance of proliferating astrocytes, this probe may be advantageous to suppress the pool of dividing astrocytes. ln addition, the 99mTc probe can potentially be used to label and monitor transplants of terminally differentiated cell types for which proliferative capacity is not a concem. These avenues will require further exploration.
The differentiation of NSPCs was examined after labeling with 99mTc, rhenium, and peptide. Although not significant, an increase in nemonal differentiation was seen when the cells were labeled with 99mTc and rhenium. The increase in neuronal differentiation is potentially useful because neuronal differentiation in vitro is typically less common than glial differentiation (27) (28) (29) . However, certain studies have demonstrated a pronounced neuronal differentiation of neurospheres (30) . This finding highlights the heterogeneity of the cellular composition in neurospheres and may explain in part the variability seen in our differentiation study. Heterogeneity within the parent spheres willlikely cause heterogeneity within the differentiated population of cells, as is reflected by the fact that some reports have found a greater population of glial cells on differentiation (29, 31) whereas other studies have found a greater population of neuronal cells (30) . Although there is variability in the present differentiation study, the 99mTc-Iabeled group consistently showed greater neuronal differentiation, suggesting that the radioactivity enhances the ability of the NSPCs to adopt a neuronal fate. This greater neuronal differentiation, in combination with the decrease in cell proliferation, may be of value for certain transplantation studies in which, typically, low numbers of neurons are seen (32) . The mechanism by which 99mTc favors neuronal differentiation requires further investigation.
In addition to studying the impact of the labels on cells, we compared data from SPECT/CT images after transplantation with phosphorimaging and fluorescence histology. Cell transplants were readily identified in coronal sections of the rat brain using phosphorimaging. When double-labeled with 99mTc and cell-tracker orange, the cells could be identified by both SPECT and histology and both were localized to the same area, thereby demonstrating the accuracy of the in vivo imaging technique.
Despite attempts to repeat injections with the same number of cells into both animais, the number of implanted cells varied. We also observed this variation in our previous study, in which we attempted to perform equal bilateral transplants but found an uneven distribution of cells between the 2 transplant sites (21) . The ability to determine the number of cells in the transplant site highlights an important benefit of labeling the NSPCs for SPECT. Previous work has shown that the number of transplanted cells affects the outcome of cell therapy. When the number of transplanted cells was varied from 25,000 to 200,000 cells/ f.1L in a rodent mo deI of PD, animais receiving a greater number of cells had significantly greater improvements in their functional recovery than did animais receiving a smaller graft (14) . In addition, larger grafts contained more tyrosine hydroxylase immunoreactive neurons and enhanced the survival rate of the transplanted cells (14) . This finding was supported by a recent study demonstrating a decrease in graft volume, cell survival, and tyrosine hydroxylase immunoreactivity in transplants when a low number of cells was injected (13) . Larger graft volumes may stimulate the release of trophic factors and establish a better intercellular environment to increase survival and the ability to adopt a dopaminergic cell fate. Therefore, the ability to determine the number of transplanted cells may aid in predicting therapeutic outcome. Many strategies have been undertaken to label stem cells (33) (34) (35) (36) (37) (38) ; however, ali these methods have been complicated by expense, lack of availability of the isotope, poor cellular uptake, or undefined biologic effects on the cells. The 99mTc probe reported here does not compromise the integrity of the DNA or the viability of the cells at the time points we examined; however, a decrease in the proliferation of NSPCs was observed. Previous data indicate that proliferation may decrease for only the first 24 h after labeling. It will be important to determine whether the decrease in proliferation is due to radiolytic damage that is not repaired or whether proliferation is slowed because of cell cycIe arrest that occurs while the cells repair the damage. Because 99mTc has a 6-h half-life, the monitoring of cell transplants must be done during the first 24 h. Although this timing does not allow for long-term monitoring of the cells, it does provide a method to characterize the initial transplant. Using this method, the number of cells that are successfully transplanted can be determined, and this number has been shown, in animal models, to affect therapeutic outcome (13, 14) . This determination is important to standardize the transplantation technique and enhance experimental control in precIinical and cIinical settings. Such an achievement may lead to more reproducible and predictive outcomes.
CONCLUSION
We assessed the effects of the 99mTc probe on proliferation and differentiation of NSPCs. When the 99mTc probe was used to monitor the cell transplants, decreases were seen in the proliferation of NSPCs in cuIture. However, no significant changes were found in differentiation of the cells. The accuracy of the SPECT images was validated using histochemistry and phosphorimaging. This labeling SPECT ANOTECHNETIUM IMAGING VALIOATION • Gleave et a!.
technique allows for visualization of the transplanted cells and quantification of the number of cells within the transplant site. This information will be useful in standardizing cellular transplantations to achieve reproducible outcomes.
